The Lead Episode 141: A Discussion of Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis-The Lead Episode 141 Speaker and Article Information

The Lead Episode 141 Speaker and Article Information

Pdf Summary

This document outlines a hosted discussion of a research article examining whether GLP‑1 receptor agonist therapy influences atrial fibrillation (AF) recurrence after catheter ablation in obese patients, using real‑world data. The featured article is titled “Impact of GLP‑1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real‑World Data Analysis,” authored by Sandrine Venier, Pascal Defaye, Lisa Lochon, Rémi Benali, Arnaud Bisson, Adrien Carabelli, Youssou Diouf, Peggy Jacon, and Laurent Fauchier, and published in <em>Circulation: Arrhythmia and Electrophysiology</em>.

The session is hosted by Melissa E. Middeldorp, MPH, PhD, from the University of Adelaide. Contributors to the discussion include Sheldon Litwin, MD (Medical University of South Carolina) and Abhishek J. Deshmukh, MD (Mayo Clinic).

The document also lists disclosures. Dr. Middeldorp reports no relevant disclosures, but notes honoraria/teaching/speaking/consulting with GE Healthcare. Dr. Litwin reports honoraria/teaching/speaking/consulting relationships with Axon Therapies, Novo Nordisk, Alleviant, and Corvia Medical. A disclosure heading is shown for Dr. Deshmukh, but specific details are not provided in the text excerpt.

Overall, the document serves as an informational slide or program note summarizing the topic, publication details, participants, and conflict‑of‑interest disclosures for an academic discussion focused on GLP‑1 therapy and AF outcomes after ablation in obese patients.

Keywords

GLP-1 receptor agonist therapy

atrial fibrillation recurrence

catheter ablation

obese patients

real-world data analysis

Circulation: Arrhythmia and Electrophysiology

academic hosted discussion

conflict of interest disclosures

GLP-1 therapy and AF outcomes

Venier Defaye Lochon Benali Bisson Carabelli Diouf Jacon Fauchier